JNJ Stock Report - Johnson & Johnson

Johnson & Johnson is a multinational corporation that operates in the healthcare industry. It is involved in researching, developing, manufacturing, and selling a wide range of products globally. The company operates through three segments: Consumer Health, Pharmaceutical, and Medical Devices.

In the Consumer Health segment, Johnson & Johnson offers products for babies such as JOHNSON'S and AVEENO Baby brands, oral care products under the LISTERINE brand, skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands, as well as healthcare products like TYLENOL acetaminophen products, SUDAFED cold, flu, and allergy products, BENADRYL and ZYRTEC allergy products, MOTRIN IB ibuprofen products, NICORETTE smoking cessation products, and PEPCID acid reflux products.

In the Pharmaceutical segment, Johnson & Johnson produces prescription drugs for a variety of diseases and conditions, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, psoriasis, HIV/AIDS, COVID-19, mood disorders, neurodegenerative disorders, schizophrenia, prostate cancer, hematologic malignancies, lung cancer, bladder cancer, thrombosis, diabetes, and macular degeneration.

The Medical Devices segment produces products for the treatment of cardiovascular diseases, hemorrhagic and ischemic stroke, hips, knees, trauma, spine, sports, breast aesthetics, ear, nose, and throat procedures, disposable contact lenses, and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand.

Johnson & Johnson was founded in 1886 and is headquartered in New Brunswick, New Jersey. The company has a global presence and serves a wide range of customers, including general public, retail outlets, distributors, wholesalers, hospitals, and healthcare professionals.

Stock Sector: Drugs: Manufacturers - Major